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Abstract
Background:  Pseudomonas aeruginosa is the major pathogen associated with chronic and
ultimately fatal lung infections in patients with cystic fibrosis (CF). To investigate how P. aeruginosa-
derived vesicles may contribute to lung disease, we explored their ability to associate with human
lung cells.
Results: Purified vesicles associated with lung cells and were internalized in a time- and dose-
dependent manner. Vesicles from a CF isolate exhibited a 3- to 4-fold greater association with lung
cells than vesicles from the lab strain PAO1. Vesicle internalization was temperature-dependent
and was inhibited by hypertonic sucrose and cyclodextrins. Surface-bound vesicles rarely
colocalized with clathrin. Internalized vesicles colocalized with the endoplasmic reticulum (ER)
marker, TRAPα, as well as with ER-localized pools of cholera toxin and transferrin. CF isolates of
P. aeruginosa abundantly secrete PaAP (PA2939), an aminopeptidase that associates with the surface
of vesicles. Vesicles from a PaAP knockout strain exhibited a 40% decrease in cell association.
Likewise, vesicles from PAO1 overexpressing PaAP displayed a significant increase in cell
association.
Conclusion: These data reveal that PaAP promotes the association of vesicles with lung cells.
Taken together, these results suggest that P. aeruginosa vesicles can interact with and be
internalized by lung epithelial cells and contribute to the inflammatory response during infection.
Background
Pseudomonas aeruginosa is the major pathogen associated
with chronic and ultimately fatal lung infections in
patients with cystic fibrosis (CF). Current research sug-
gests that P. aeruginosa live anaerobically in the mucus
layer of the CF lung and are rarely found in contact with
epithelial cells [1,2]. Extracellular proteases are secreted
by P. aeruginosa, including Las A, elastase, alkaline pro-
tease, and protease IV, and these are known contributors
to virulence in lung infections [3-5]. Like other gram neg-
ative bacteria, P. aeruginosa also release spheres of outer
membrane known as outer membrane vesicles [6]. They
consist of entrapped periplasmic components and outer
membrane constituents, including lipopolysaccharide
(LPS), glycerophospholipids, and outer membrane pro-
teins (OMPs) [7]. Due to their small size, vesicles poten-
tially gain access to host cells more easily than whole
bacteria. Considering that vesicles are armed with bacte-
rial proteases, toxins, surface adhesins and/or invasins,
vesicles present a potentially significant contributor to
lung damage caused by P. aeruginosa. Since they contain
many immunostimulatory compounds, it is not surpris-
ing that P. aeruginosa vesicles induce a significant IL-8
response from cultured human lung cells [8].
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Vesicles allow bacteria to disperse a complex of soluble
and insoluble bacterial products into the surrounding
milieu. Vesiculation appears to be a conserved process
among both pathogenic and non-pathogenic bacteria and
the role of outer membrane vesicles in pathogenesis is a
burgeoning area of research [9]. Many pathogenic bacte-
rial species aside from P. aeruginosa produce vesicles that
contain toxins or other virulence factors and, in several
cases, vesicles have been proposed to be vehicles for toxin
delivery to eukaryotic cells [10-16]. In order to deliver
toxic content, vesicles must first bind to host cells. Vesicles
from Shigella flexneri [17], Borellia burgdorferi [18], Actino-
bacillus actinomycetemcomitans [13,19] and ETEC [14,20]
have been observed to bind cultured host cells. Vesicles
have also been observed interacting with host cells in vivo.
In biopsies of infected patients, vesicles from H. pylori
were found to bind intestinal cells [10,21].
P. aeruginosa vesicles have been amongst the most thor-
oughly studied vesicles to date. They have been shown to
contain the virulence factors pro-elastase, hemolysin,
phospholipase C, and alkaline phosphatase, as well as the
penicillin-degrading enzyme β-lactamase and the Pseu-
domonas quorum sensing signal (PQS) and other hydroxy-
alkylquinolones [22-24]. We recently reported that the
secreted aminopeptidase, PaAP, is enriched in outer mem-
brane vesicles that we purified from each of the tested CF
strains of P. aeruginosa [8]. Interestingly, PaAP expression
was found to increase 21-fold when PAO1 was grown
under microaerobic conditions [25], and 103-fold when it
was grown in the presence of primary lung epithelial cells
[26]. An analogous zinc metalloprotease was discovered
to be associated with vesicles produced by a different CF
pathogen, Burkholderia cepacia, and a strain with a knock-
out in this gene was less virulent in an animal model [27].
Such studies have stimulated much interest in determin-
ing how vesicles and vesicle components contribute to P.
aeruginosa infection and disease in the lungs.
In this study, we use both cultured and primary airway
epithelial cells to investigate vesicle-host cell interactions
and to assess the contribution of PaAP to this interaction.
We report that P. aeruginosa vesicles are internalized by
human lung cells and PaAP increases vesicle association
with lung cells. The results point to physiological roles for
P. aeruginosa PaAP and vesicles during an infection.
Results
P. aeruginosa vesicle association with lung epithelial cells 
is strain-dependent
We examined whether vesicles from various P. aeruginosa
isolates would associate with cultured human respiratory
epithelial cells. Fluorescently labeled vesicles (FITC-vesi-
cles) from late log-phase cultures were incubated with
A549 human lung epithelial cells and the amount of ves-
icles associated with host cells after incubation at 37°C
was quantitated using a previously established microtiter
plate assay [14]. To account for minor variability in the
fluorescent labeling of vesicles, the amount of cell-associ-
ated vesicles was extrapolated from standard curves relat-
ing fluorescence to ng of FITC-vesicles for each of the
vesicle preparations. Cell-associated fluorescence
increased over time for vesicles for each of the P. aerugi-
nosa isolates, however significantly more (3.3-fold) vesi-
cles from the CF isolate S470 associated with A549 cells
compared with PAO1 vesicles (Fig. 1A). The cell associa-
tion profile for vesicles from another CF isolate, CF2, was
very similar to the one exhibited by S470, and host cell
association of vesicles from all isolates was dose-depend-
ent (data not shown).
To test whether the vesicles would interact similarly with
primary cells, we incubated vesicles with human bron-
chial epithelial (HBE) cells from healthy human volun-
teers (Fig. 1B). The results for the HBE cells were similar to
those with cultured cells, thus cultured cells appeared to
be a good model for primary cells in further assays.
Together, these data indicate that P. aeruginosa vesicles
from CF strains associate to a greater extent with epithelial
cells than vesicles from a non-CF strain.
When we tested temperature dependence of vesicle-host
cell association we found that incubation at 4°C substan-
tially decreased the amount of S470 vesicles associated
with the lung cells, whereas little-to-no difference was
observed for PAO1 vesicles (Fig. 2A). These data indicate
that a temperature-dependent mechanism was responsi-
ble for the differences observed in the association between
vesicles from a CF strain and vesicles from a non-CF
strain.
Pseudomonas aeruginosa vesicles are trafficked into lung 
epithelial cells
Temperature-dependent association of S470 vesicles sug-
gested that these vesicles may be internalized by the lung
epithelial cells. We used confocal microscopy to analyze
vesicle-host cell interactions. Cultured A549 cells were
incubated with FITC-labeled S470 vesicles for 6 hours at
37°C, and plasma membranes were stained with AF633-
wheat germ agglutinin (WGA) to visualize cell bounda-
ries. At 37°C, vesicle fluorescence appeared to be mostly
internal and concentrated in a perinuclear region of the
cell (Fig. 2B). Very little vesicle association was observed
for incubations maintained at 4°C (Fig. 2C). Thus, both
binding and internal localization of S470 vesicles was
affected at the lower temperature.
To further confirm vesicle internalization, vesicles were
labeled using AF488 instead of FITC to maximize fluores-
cence and minimize the effects of photobleaching. ManyBMC Microbiology 2009, 9:26 http://www.biomedcentral.com/1471-2180/9/26
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vesicle components are labeled by this reagent (Fig 3A),
indicating that the fluorescent signal would not track
merely a single component. After incubating AF488-S470
vesicles with A549 cells for 1 h at 37°C, the surface of cell
monolayers was labeled with a membrane-impermeable
biotin. The biotinylated surface was then detected using
AF633-streptavidin and cell fluorescence was visualized
by confocal microscopy. As a result, surface-exposed vesi-
cles appear white and internalized vesicles appear green in
an overlay of streptavidin and vesicle fluorescence. After a
1 hour incubation with A549 cells, mainly green, perinu-
clear fluorescence was observed (Fig 3B), with only a few
white, surface localized vesicles (indicated by arrows, Fig
3B), indicating that S470 vesicles are internalized by lung
cells.
To investigate the mode of P. aeruginosa vesicle internali-
zation, we treated cells with common inhibitors of endo-
cytic pathways. Filipin, chlorpromazine, cytochalasin D,
and NiCl2 did not inhibit uptake (data not shown). Pre-
treatment of cells with methyl-β-cyclodextrin (MβCD),
which removes cholesterol from membranes, inhibited
vesicle uptake, however, preincubation with methyl-α-
cyclodextrin, which typically is used as a negative control
for MβCD, inhibited vesicle uptake as well (Fig. 3C and
3D). Inhibition of vesicle uptake was also achieved using
hypertonic sucrose (Fig 3E). In parallel control incuba-
tions, we pretreated vesicles with hypertonic sucrose or
cyclodextrins instead of pretreating the lung cells. In these
controls, vesicles were still readily internalized (data not
shown), indicating that the inhibition of vesicle uptake
was due to effects on the lung cells and not on the vesicles
themselves.
Since we observed the greatest effect on vesicle internali-
zation using hypertonic sucrose and MβCD, which impair
clathrin-coated pit formation and invagination, respec-
tively [28,29], we next investigated whether vesicles
would colocalize with clathrin. We observed a few loca-
tions where vesicle fluorescence colocalized with clathrin
on the cell surface, however vesicle fluorescence did not
co-localize with any intracellular clathrin (Fig 4). Vesicles
did not colocalize with any caveolin, however it should be
noted that very little caveolin was visualized in the A549
cells, consistent with reports of low levels of caveolin-1
expression in these cells [30,31] (data not shown). These
data suggest that vesicles may be associated with clathrin-
coated pits, but only transiently, at an early stage in the
active uptake process.
Internalized vesicle components colocalize with the 
endoplasmic reticulum
We repeatedly observed internalized vesicle-associated
fluorescence localized to a perinuclear region. We exam-
ined whether vesicles were trafficked to the same compart-
ments as transferrin and cholera toxoid (CTB). Only
transferrin and CTB that were perinuclear colocalized with
internalized vesicles, whereas the majority of cytosolic
compartments containing transferrin and CTB did not
[see Additional file 1]. To determine whether this perinu-
clear region corresponded to the endoplasmic reticulum
(ER), we treated cells with the glycoside digitonin, which,
at low concentrations, permeabilizes the plasma mem-
brane and releases cytosolic proteins but preserves the ER
membrane [32,33]. After digitonin treatment, cells that
had lost the cytoplasmic marker, β-tubulin, still retained a
perinuclear halo of vesicle-associated fluorescence (data
Vesicles from a CF isolate associates to a greater extent with  lung cells compared to PA01 vesicles Figure 1
Vesicles from a CF isolate associates to a greater 
extent with lung cells compared to PA01 vesicles. 
FITC-labeled vesicles (2.5 μg per well) were incubated with 
confluent monolayers of approximately 5 × 104 A549 cells (A) 
or HBE cells (B) for indicated times at 37°C. Fluorescence 
associated with washed, solubilized cells was quantitated and 
correlated to vesicle amount using standard curves gener-
ated for vesicles from each strain. Experiments were done in 
triplicate, SEM is indicated for 2 to 7 separate experiments. 
At the 24 h time point, p < 0.001 for each data set.
A
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not shown). In these treated cells, vesicle fluorescence
clearly colocalized with the integral ER membrane protein
TRAPα (Fig. 5). These data suggest that internalized vesi-
cle components traffic to the ER within 1 hour of expo-
sure.
PaAP promotes vesicle association with human respiratory 
epithelial cells
We wondered whether host cell association depended on
PaAP, one of the major protein components of vesicles
derived from CF isolates (Fig 6A). Quantitative 2D-DIGE
revealed PaAP is at least 65-fold enriched in S470 vesicles
compared with PAO1 vesicles [8]. To test whether PaAP
on vesicles contributed to host cell association, we overex-
pressed PaAP in PAO1 (PAO1/pS41) and constructed a
deletion in the aminopeptidase in strain S470
(S470APKO5). We confirmed that purified PAO1/pS41
vesicles were enriched in PaAP compared with PA01 vesi-
cles and that S470APKO5 did not contain detectable
amounts of PaAP [see Additional file 2]. Purified PAO1/
pS41 vesicles associated with A549 cells more than twice
as much as PA01 vesicles, whereas S470APKO5 vesicles
associated 40% less with the lung cells than S470 vesicles
(Fig. 6B, C). Unfortunately, complementation of
S470APKO5 was not successful since vesicles from
S470APKO5 expressing PaAP from pS41 contained
approximately 10-fold less PaAP and had 10-fold less
aminopeptidase activity than S470 vesicles [see Addi-
tional file 3, parts A and B]. Induction of PaAP expression
in S470APKO5 did not help correct the complementation
defect and increase the level of vesicle-bound PaAP,
although the total amount of PaAP in the supernatant was
equivalent to that of S470 [see Additional file 3, part C].
As a result, it was not surprising that S470APKO5/pS41
vesicles associated with host cells to approximately the
same extent as those from APKO5 (data not shown). Col-
lectively, these data support a dose-dependent contribu-
tion of PaAP to the association of vesicles with host cells.
Discussion
With these results, we have revealed several facets of inter-
actions between P. aeruginosa vesicles and human lung
epithelial cells. We have demonstrated that P. aeruginosa
vesicles are internalized by epithelial cells and trafficked
intracellularly so that vesicle components accumulate in
the ER. We have also shown that PaAP, an enzyme more
abundant in vesicles produced by many CF isolates com-
pared with non-clinical isolates, significantly contributes
to the interaction of P. aeruginosa vesicles with host cells.
Internalization by host cells has been reported to occur for
outer membrane vesicles from numerous species. For
instance, our lab has shown previously that ETEC vesicles
are internalized in an LT-dependent fashion via ganglio-
side GM1 in caveolin-enriched lipid rafts of epithelial cells
[20]. Additionally, fluorescent beads coated with Porphy-
romonas gingivalis vesicles also colocalized with caveolin
and GM1 and were internalized by HeLa cells in a choles-
terol and dynamin-dependent manner [34]. Our observa-
tions regarding the temperature-dependent extent and
location of vesicle-associated fluorescence in host cells
and decreased fluorescence in host cells upon pretreat-
ment with methyl-β-cyclodextrin (which disrupts caveo-
lae, lipid rafts, as well as clathrin-coated pit-mediated
entry pathways) suggested that S470 vesicles were also
internalized.
S470 vesicle association with host cells is temperature- dependent Figure 2
S470 vesicle association with host cells is tempera-
ture-dependent. A, FITC-labeled-vesicles (2.5 μg per well) 
were incubated with A549 cells (5 × 104 cells per well) for 24 
h at 37°C (black bars), or 4°C (gray bars). SEM is indicated, 
n≥2, in triplicate. B and C, A549 cells alone (left panels) or 
incubated with 2.5 μg FITC-labeled S470 vesicles (green, 
right panels) for 6 h at 37°C (B) or 4°C (C). After incubation, 
cells were washed, labeled with AF633-WGA (blue), fixed in 
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In contrast to other examples of internalized vesicles, P
aeruginosa vesicles appear to enter host cells via multiple
pathways. Hypertonic media, which impairs clathrin
coated pit formation, did significantly decrease vesicle
internalization and some surface-bound vesicles were
found colocalized with clathrin. However, neither treat-
ment with filipin, which disrupts lipid rafts, nor chlorpro-
mazine, which blocks clathrin-coated pits, decreased
vesicle internalization significantly. It should also be con-
sidered that P. aeruginosa vesicles could fuse with the epi-
thelial cells and that vesicle membrane components are
subsequently internalized by plasma membrane traffick-
ing while lumenal components are liberated into the host
cell cytosol. Evidence of fusion of vesicles with the plasma
membrane has been presented for Actinobacillus actinomyc-
etemcomitans vesicles [13]: Confocal microscopy of HL60
cells coincubated with these vesicles showed immediate
and strong labelling, primarily at the plasma membrane.
We did not observe strong perimeter labelling of host cells
with  P. aeruginosa vesicles (Fig 2B). In fact, when we
blocked active transport with hypertonic sucrose, we
found a significant decrease in vesicle-associated fluores-
cence, not accumulation of fluorescence at the cell periph-
ery (Fig 3E). Thus, our data support a model where P.
aeruginosa vesicles do not fuse to the plasma membrane,
but instead bind and are internalized.
We observed an increase in human lung epithelial cell-
associated fluorescence over time. This result is consistent
with either vesicle attachment causing receptor upregula-
tion, or continuous vesicle binding, internalization, recy-
cling of vesicle receptors to the cell surface. These
characteristics are similar to the behavior of enterotoxi-
genic E. coli vesicles with intestinal epithelial cells [14].
Further experiments using different inhibitors, markers,
and cell lines, will be necessary to definitively identify the
host cell factors critical to P. aeruginosa vesicle entry. In
relation to CF-related research, it would be particularly
interesting to see whether the interactions depend on
functional and properly localized CFTR. Ceramide-rich
rafts containing clusters of the CFTR and CD95 have been
implicated as the means for internalization of whole P.
aeruginosa. These rafts are disrupted by MβCD, and thus in
light of our MβCD treatment results, they present a poten-
tial route for vesicle internalization [35].
Once internalized, vesicles may be sequestered, degraded,
or their components may be dispersed, with their mem-
branes disrupted and/or fused with the endocytic mem-
brane. In the case of S. flexneri vesicles, for instance, vesicle
lumenal content was found in the host cell cytosol after
vesicles were phagocytosed to a non-acidified compart-
ment by Henle 407 epithelial cells [36]. We show that P.
aeruginosa vesicle-associated intracellular fluorescence is
concentrated to bright puncta and do not encounter an
acidified compartment, since vesicle-associated FITC fluo-
rescence (which is pH sensitive) is not quenched, even in
long incubations (Fig 1). Notably, a significant amount of
vesicle-associated fluorescence colocalized with the inte-
gral ER membrane protein TRAPα, even after a relatively
brief incubation time. Transferrin and CT eventually route
to the ER, and indeed, those pools of Transferrin and CT
that had reached the ER colocalized with the vesicle fluo-
rescence. None of the currently identified P. aeruginosa
vesicle proteins have an ER retention sequence to direct
the trafficking of these bacterial factors to the ER (such as
the case for LT which has RDEL at its C-terminus). Since
intracellular trafficking of S470APKO5 vesicles was not
Vesicle components are internalized by lung cells, and inter- nalization is inhibited by hypertonic sucrose and cyclodex- trins Figure 3
Vesicle components are internalized by lung cells, 
and internalization is inhibited by hypertonic sucrose 
and cyclodextrins. A, SDS-PAGE gel profiles of S470 vesi-
cles before and after AF488 labeling. Total protein in unla-
beled vesicles was visualized after SYPRO Ruby staining of 
the gel (R). AF488-labeled proteins were visualized by placing 
the unstained gel on a UV lightbox (F). The migration of 
molecular weight standards (kDa) and PaAP (arrow) is indi-
cated. B, A549 cells incubated with 2.5 μg AF488-labeled 
S470 vesicles (green) for 1 h at 37°C. Cell surface was 
labeled using biotin and AF633-streptavidin (blue), fixed in 2% 
paraformaldehyde, and visualized by confocal microscopy. 
A549 cells were pretreated with 10 mM methyl-β-cyclodex-
trin (C), 10 mM α-cyclodextrin (D), or 0.45 M sucrose (E), 
for 30 minutes, and then incubated with 2.5 μg AF488-
labeled S470 vesicles (green) for 1 h at 37°C. Cell surface 
was labeled using biotin and AF633-streptavidin (blue), fixed 
in 2% paraformaldehyde, and visualized by confocal micros-
copy. Bars indicate 25 μm.BMC Microbiology 2009, 9:26 http://www.biomedcentral.com/1471-2180/9/26
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noticeably different from S470 vesicles (data not shown),
internalized vesicle trafficking appears to be PaAP-inde-
pendent. In all, many questions remain regarding the traf-
ficking of P. aeruginosa vesicle membrane and lumenal
content after endocytosis, and this area deserves further
exploration.
In some cases the factor on bacterial vesicles responsible
for host cell binding has been identified as a virulence fac-
tor [9]. For example, the heat-labile enterotoxin (LT) is
bound to the surface of ETEC vesicles, and vesicle-bound
LT mediates vesicle binding to cultured eukaryotic cells
via the LT receptor, ganglioside GM1 [11,14]. In contrast,
leukotoxin transported in A. actinomycetemcomitans vesi-
cles was not responsible for vesicle association with HL60
cells [13]. We have found that PaAP also is located on the
vesicle surface (preliminary data), and that host cell asso-
ciation correlated with PaAP levels on the vesicles. Strains
overexpressing PaAP or deleted in PaAP, respectively, pro-
duced vesicles that associated to a greater or lesser extent
than vesicles from the corresponding isogenic parent
strains. A direct correlation between vesicle association
and PaAP levels also held for strains naturally expressing
PaAP at different levels. PaAP expression is highly regu-
lated and typically does not occur until stationary phase
[37-40]. This was true for our cultures of PAO1, and as a
result PaAP was nearly absent from PAO1 vesicles purified
from late log-phase cultures (see Fig 6 and [Additional file
2, Part A]). In contrast, strain S470 begins to express PaAP
in late log phase, therefore PaAP was enriched in the late
log-phase S470 vesicles (see Fig 6 and [Additional file 2,
Part A]). Correspondingly, PAO1 vesicles associated 3–4
fold less than S470 vesicles (Fig 1). Thus, the degree of
bacterial vesicle-host cell interaction can depend on the
growth phase of the parent bacterium. Despite the impor-
tance of PaAP, it is not the only factor governing host cell
association since association by S470APKO5 vesicles was
only reduced by 40% compared with S470 vesicles. The
conclusion that P. aeruginosa vesicles can utilize numer-
ous internalization pathways is consistent with our find-
ing that factors other than PaAP are involved in vesicle-
host cell association.
We describe that PaAP expression in trans failed to com-
plement the PaAP deletion with regards to the ability to
obtain WT levels of vesicle-localized PaAP, and hence its
ability to restore WT levels of vesicle association with host
cells. Complemented PaAP was expressed and secreted
into the culture supernatant at WT levels, however it was
not found in the vesicle-associated fraction [see Addi-
tional file 3]. In fact, overexpression of PaAP in the null
mutant resulted in reduced viability (unpublished data).
This lack of functional complementation is not unprece-
dented. Two other secreted P. aeruginosa proteases (LasA
and protease IV) have knockout phenotypes which could
not be complemented by expression of the gene from a
plasmid or even from a chromosomal insertion [41-43].
The lack of complementation by the plasmid-expressed
PaAP in the APKO5 PaAP knockout strain demonstrates
the likelihood of a fine-tuned regulatory process that is
critical for optimal PaAP expression, processing, stability,
and/or secretion. Indeed, PaAP has been found to
undergo complex post-translational processing ((D. Fit-
zGerald, personal communication, and [44]).
Since vesicle-associated PaAP has activity as a zinc-
dependent protease, PaAP could act as a proteolytic factor
that exposes vesicle receptors on the host cell surface. In
an attempt to test this, we constructed a mutant PaAP
which lacked active site residues however it was not
secreted (preliminary data). Interestingly, this suggests
PaAP must bind zinc for it to fold correctly and folding is
critical for export of Type 2 secretory pathway substrates.
As a result, we have not yet been able to test whether PaAP
activity is important in mediating host cell interactions,
internalization, or trafficking.
We discovered several characteristics of PaAP expression
relevant to the virulence of P. aeruginosa in the CF lung.
First, strains taken from patients with CF express PaAP
abundantly. Second, we found that more PaAP is detecta-
ble in vesicles produced by PA01 that contain the β-lacta-
mase-resistant vector pMMB66EH than in those produced
by PA01 [see Additional file 2, part A]. The association of
these vesicles with lung cells was consistent with the pre-
viously described trend: PAO1/pMMB66EH vesicles asso-
ciated with host cells to a greater extent compared to PA01
vesicles [see Additional file 2, part B]. The increase in
PaAP expression in this case appears to be due to the pres-
Vesicles rarely co-localize with surface-associated clathrin Figure 4
Vesicles rarely co-localize with surface-associated 
clathrin. AF488-S470 vesicles (2.5 μg) were incubated with 
A549 cells for 1 h at 37°C. Cell surface was labeled using 
biotin and AF633-streptavidin (blue). Cells were washed, 
fixed, permeabilized, and probed with mouse anti-clathrin 
antibodies and AF555-labeled goat anti-mouse secondary 
antibody. Arrows indicate very occasional colocalization of 
clathrin and vesicle fluorescence at the cell surface.
Clathrin
S470
Vesicles Merge Cell surfaceBMC Microbiology 2009, 9:26 http://www.biomedcentral.com/1471-2180/9/26
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ence of antibiotics in the media, which is particularly rel-
evant considering that bacteria in the CF lungs are
frequently exposed to antibiotics. Finally, sera from CF
patients contained antibodies to several vesicle proteins,
and a subset of patients (3 out of 13) produced antibodies
to PaAP indicating that PaAP is expressed and secreted in
CF patients (Fig. 7). These findings suggest that the condi-
tions present in infected CF lungs promote upregulation
of P. aeruginosa PaAP and production of vesicles that con-
tain PaAP.
Conclusion
Purified P. aeruginosa vesicles associate with human lung
cells and are internalized in a time- and dose-dependent
manner. Vesicles from a CF isolate exhibit greater associa-
tion with lung cells than vesicles from a lab strain. Vesicle
internalization is temperature-dependent and inhibited
by hypertonic sucrose and cyclodextrins. Vesicles also
appear to be very transiently associated with clathrin-
coated pits as part of an active uptake process. After inter-
nalization, vesicle components were found to colocalize
with the ER. Tested CF isolates of P. aeruginosa abundantly
secrete PaAP, an aminopeptidase which is a major con-
tributor to lung cell association. Therefore, our results sug-
gest that P. aeruginosa vesicles can interact with and be
internalized by lung epithelial cells and thereby contrib-
ute to the inflammatory response during infection.
Methods
Bacterial strains and reagents
P. aeruginosa strains used were the laboratory strain PA01
(Pf1 phage-cured from our lab collection), the soil isolate
ATCC 14886 (American Type Culture Collection, isolated
prior to 1958), and minimally passaged, non-mucoid
cystic fibrosis clinical isolates CF2, CF3, CF4, and S470
(Duke University Hospital). A549 human lung epithelia
carcinoma cells were grown according to ATCC specifica-
tions in Kaighn's F-12K media containing 10% fetal
bovine serum plus penicillin/streptomycin/fungizone.
Human bronchial epithelial (HBE) cells were derived
from anonymous healthy human volunteers. HBE cells
were maintained in Bronchial Epithelial Cell Growth
Media supplemented with thyroid extract. Unless indi-
cated, all reagents were purchased from VWR.
Construction of PA01 overexpressing PaAP (PA01/pS41)
The PA2939 gene encoding PaAP was amplified from
strain S470 using the primers given in Table 1, which
added an EcoRI site to the 5' end of the sequence a HindIII
site to the 3' end of the sequence. The gene was subcloned
into pBluescript and then moved to pMMB66EH (pro-
vided by Erich Lanka) to make plasmid pS41. Plasmid
pS41 was moved into PA01 by triparental mating as
described [45], using HB101/pS41 as the donor strain and
MK616 (containing pRK2013) as the helper strain. Suc-
cessful conjugants were selected on Pseudomonas Isola-
tion Agar (PIA) supplemented with carbenicillin (200 μg/
ml) and verified by restriction digestion of miniprepped
DNA.
Construction of PA2939 knockout in S470 (strain APKO5)
The PA2939 knockout vector (pAPKO) was constructed
by interrupting the PA2939 sequence with a Tet cassette.
DNA sequence starting from approximately 500 bp
upstream of the PA2939 start codon to 30 bp into PA2939
was amplified by PCR using the "up" primers given in
Table 1, which added a SpeI site to the 5' end of the DNA
and mutated the 3' end to contain an EcoRI site. The
remainder of the PA2939 sequence was amplified with
the "down" primers given in Table 1, which mutated the
5' end to contain an EcoRI site and added an XhoI site to
3' end. The Tet cassette was amplified from plasmid
pACYC184 using primers given in Table 1 that added
EcoRI sites to both ends. The three pieces were combined
sequentially using the pDrive subcloning vector (Qiagen).
The final construct was cut out of pDrive using SpeI and
XhoI sites and inserted into the MCS of pJQ200SK (GmR,
SacB) to make plasmid pAPKO.
Triparental mating was used to introduce pAPKO into
strain S470 using HB101/pAPKO as the donor strain, and
MT616 as the helper strain. Successful conjugants were
first selected on 1/2 PIA Tet (200 μg/ml) and Gm (20 μg/
ml). Bacterial colonies that had undergone homologous
recombination with the DNA containing the interruption
of PA2939 were then counter-selected for resistance to Tet
and sensitivity 5% sucrose and Gm. Knockout
S470APKO5 was verified by PCR amplification of the
Vesicles co-localize with the endoplasmic reticulum marker  TRAPα Figure 5
Vesicles co-localize with the endoplasmic reticulum 
marker TRAPα. AF488-S470 vesicles (2.5 μg) were incu-
bated with A549 cells for 1 hour at 37°C. Cell surface was 
labeled using biotin and AF633-streptavidin (blue). Cells were 
washed, fixed, permeabilized with 0.015% digitonin to release 
cytoplasm, and probed with anti-TRAPα primary antibody 
and AF555-labeled secondary antibody.BMC Microbiology 2009, 9:26 http://www.biomedcentral.com/1471-2180/9/26
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interrupted PA2939 sequence, sequencing of the inter-
rupted gene, and immunoblotting with anti-PaAP.
S470APKO5 was complemented with vector pS41 or
empty vector pMMB66EH by triparental mating, as
described above. Complementation was verified by PCR,
restriction digests of plasmid DNA, and aminopeptidase
detection by immunoblot and activity.
Vesicle isolation and purification
Vesicles were purified from a method adapted from Horst-
man and Kuehn [11]. Bacteria were grown in LB broth
overnight to early stationary phase. Cells were removed by
pelleting (10,000 × g, 10 min). Supernatants were concen-
trated via a 100-kDa tangential filtration concentration
unit (Pall-Gellman) to approximately 1/25th their original
volume. The retentate was collected and centrifuged
(6000 × g, 10 min) and then filtered through a 0.45 μm
Durapore PVDF filter (Millipore) to remove remaining
bacterial cells. Vesicles were obtained from the cell-free
supernatant by one of two methods. In the first method,
the vesicles were pelleted (39,000 × g, 1 h), resuspended
in 50 mM HEPES, pH 6.8 (HEPES), and adjusted to 45%
Optiprep (Greiner) in 10 mM HEPES/0.85% NaCl, pH
7.4 (HEPES-NaCl) (weight/weight). In the second
method, the vesicles were precipitated with 71–75%
ammonium sulfate (4°C, for at least 3 h), pelleted
(10,000 × g, 20 min), dialyzed overnight with HEPES,
concentrated (50 kDa MWCO Centriplus, Millipore), and
adjusted to 45% Optiprep/HEPES-NaCl. Optiprep gradi-
ents were layered over the 2 ml crude vesicle samples as
follows: For PAO1: 2 ml 40%, 2 ml 35%, 3 ml 30%, 2 ml
25%, 1 ml 20%; for Soil: 2 ml 40%, 2 ml 35%, 2 ml 30%,
2 ml 25%, 2 ml 20%; for CF isolates: 2 ml 40%, 2 ml 35%,
4 ml 30%, 2 ml 20% Optiprep/HEPES-NaCl by weight.
Gradients were centrifuged (100,000 × g, 16 h) and 1 ml
fractions removed from the top. A portion of each fraction
was visualized by 15% SDS-PAGE. Pure vesicles were
recovered from pooled peak fractions by dialyzing over-
night against HEPES and pelleting (150,000 × g, 1 h). Ves-
icles were checked for sterility by culturing 5–50 μL on LB
agar overnight at 37°C. Contaminated vesicles were fil-
tered through 0.45 μm Microcon spin filters (Millipore)
and recultured on LB plates.
Fluorescent labeling of vesicles
Purified vesicles were fluorescently labeled by incubating
with fluorescein isothiocyanate (FITC) reagent (Sigma)(1
μg FITC/μg vesicle protein in 100 mM NaCl/50 mM
Na2CO3, pH 9.2), for 2 h at 25°C with mixing, or with
AlexaFluor-488 succinimidyl ester (AF488, Invitrogen, in
0.1 M Na2CO3, pH 9) according to manufacturer's instruc-
tions, for 1 h at 25°C with mixing. Free FITC and AF488
were removed from labeled vesicles by washing three
times in HEPES (150,000 × g, 30 min). Labeled vesicles
PaAP is abundant and active in vesicles from CF strains and  promotes the association of P. aeruginosa vesicles with lung  cells Figure 6
PaAP is abundant and active in vesicles from CF 
strains and promotes the association of P. aeruginosa 
vesicles with lung cells. A, Purified vesicles (approximately 
10 μg) were TCA-precipitated and analyzed using SDS-PAGE 
and Coomassie staining. Previously identified proteins in 
PA01 vesicles and CF2 vesicles are indicated, and (*) high-
lights the lower molecular weight form of OprD found in 
PA01 [8]. The migration of molecular weight standards is 
indicated (kDa). B and C, Purified vesicles from the indicated 
strains (2.5 μg protein/well) were incubated (24 h, 37°C) 
with confluent monolayers of A549 cells (5 × 104/well) and 
vesicle-host cell association was compared with S470 vesicle 
association within each experimental set. SEM is indicated; n 
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were checked for sterility and filtered through 0.45 μm
PVDF spin filters when necessary.
Vesicle association assays
FITC-labeled vesicles (2.5 μg per well) were incubated
with confluent monolayers (approx. 5 × 104 cells per well)
of A549 human lung epithelia or HBE cells in serum-free
media in 96-well plates (Costar) for 15 min to 24 h at
37°C or 4°C. All incubation conditions were done in trip-
licate. Cells were washed twice with PBS and then solubi-
lized in 100 μ1 1% Triton X-100 in PBS. Fluorescence was
quantitated using a FLUOstar Galaxy or FLUOstar Optima
fluorometer (BMG Labtechnologies). A standard curve to
correlate fluorescence measured in test wells to ng of ves-
icles was generated by adding purified FITC-labeled vesi-
cles (0.5 ng–250 ng) from each strain to cells and
immediately solubilizing the cells. Statistics were calcu-
lated using single-factor ANOVA.
Confocal microscopy
All fluorescence microscopy reagents were purchased
from Molecular Probes/Invitrogen unless otherwise
stated. A549 human lung epithelia (1 × 105 cells per well)
were seeded in LabTekII 8-well glass chamber slides
(VWR) and incubated with fluorescently labeled vesicles
(2.5 μg per well) in serum-free media for 1–6 h at 37°C or
4°C. When indicated, AlexaFluor-555 transferrin (25 μg/
ml) or AlexaFluor-555 cholera toxin B subunit (10 μg/ml)
were added to cells five minutes prior to the addition of
vesicles. For inhibition experiments, cells were pretreated
with inhibitors (methyl-β-cyclodextrin, 10 mM; methyl-
α-cyclodextrin, 10 mM; sucrose, 0.45 M; chlorpromazine,
1 μg/ml; filipin, 5 μg/ml; cytochalasin D, 1 μg/ml; NiCl2,
2 mM) for 30 min, and the inhibitors remained in the
media during incubation with vesicles. All subsequent
steps were carried out on ice and ice-cold Dulbecco's
phosphate-buffered saline (PBS) was used for washes.
Following incubation with vesicles, cells were washed
twice to remove unbound vesicles. Cell exteriors were
labeled in one of two ways, as indicated in figure legends:
1) Cells were incubated with AF633-conjugated wheat
germ agglutinin (WGA; 25 min, on ice) and washed twice,
or 2) Cells were incubated with 6-((biotinoyl)amino)hex-
anoic acid, succinimidyl ester (Biotin-X, SE; 10 min, on
ice), washed twice, and then incubated with AF633-conju-
gated streptavidin (15 min, on ice) and washed twice.
Cells were then fixed in 2% paraformaldehyde, mounted
with ProLong AntiFade reagent, and visualized on a
Nikon Eclipse TE200.
Immunofluorescence
Clathrin and caveolin immunofluorescence was per-
formed essentially as described [14]. Following incuba-
tion with vesicles, monolayers were washed, cell exteriors
were labeled with Biotin-X, SE/AF633-Streptavidin and
fixed as described above. Fixed cells were washed, perme-
abilized (0.1% Triton X-100 in Hanks buffer; 15 min,
25°C), blocked (5% goat serum and 0.1% bovine serum
albumin in permeabilization buffer; 20 min, 25°C), incu-
bated with mouse anti-caveolin-1 or anti-clathrin anti-
bodies (BD Biosciences; 2.5 μg/ml in permeabilization
buffer; 1 h, 25°C), washed, and then labeled with AF555-
conjugated goat anti-mouse secondary antibody (μg/ml
in permeabilization buffer; 30 min, 25°C), and washed.
Following incubation with secondary antibodies, slides
were mounted and visualized as described above.
For TRAPα and tubulin immunofluorescence, fixed mon-
olayers were permeabilized in PBS supplemented with 1
mM DTT, 1 mM PMSF, and 0.015% digitonin (to release
cytoplasmic contents) for 5 min. Permeabilized cells were
blocked with 1% BSA in PBS (30 min, on ice), incubated
with rabbit anti-TRAPα or mouse anti-β-tubulin primary
antibodies (2 μg/ml, in blocking buffer, 1 h, on ice),




KO up forward TGTAACTAGTATGGTCAGCACATGTTGCA
KO up reverse GCCAGGGATGCGGCGGAATTCGAGAGGGCGAGGGCG
KO down forward CGCCCTCGCCCTCTCGAATTCCGCCGCATCCCTGGC
KO down reverse CTGACCTCGAGTTACTTGATGAAGTCGTGAC
TetR cassette from pACYC184
EcoRI Tet forward GGTTATGAATTCGGTAGCTCAGAGAACCCTTCG
EcoRI Tet reverse GTGTTAGAATTCGATATGTTCTGCCAAGGGTT
Xho Tet forward CCGGCTCGAGGGTAGCTCAGAGAACCTTCG
Xho Tet reverse CCGGCTCGAGGATATGTTCTGCCAAGGGTTBMC Microbiology 2009, 9:26 http://www.biomedcentral.com/1471-2180/9/26
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washed, and incubated with AF555-conjugated goat anti-
mouse or anti-rabbit secondary antibodies (30 min, on
ice). Following incubation with secondary antibody,
slides were mounted and visualized as described above.
Leucine aminopeptidase assay
Assays were performed using the substrate Leu-p-nitroani-
lide (0.6 mM in 50 mM Tris-HCl, 1 mM CaCl2, pH 8.3) as
described previously [44]. Samples were preincubated
with 0.5 mM dithiothreitol (30 min, 25°C) in controls
experiments (data not shown) to demonstrate specificity.
The production of p-nitroaniline (pNA) was monitored at
405 nm.
Detection of PaAP antibodies in sera from CF patients
Outer membranes were purified as described [46,47].
Briefly, cells were harvested in stationary phase, resus-
pended (20% sucrose in 30 mM Tris, pH 8), treated with
DNase I and RNaseA and broken by French Press. Mem-
branes were separated using a sucrose gradient. Purified
S470 outer membrane and vesicles (2 μg) were separated
by SDS-PAGE and SYPRO Ruby protein stained or trans-
ferred to PVDF, immunoblotted using sera (1:10 dilution)
from anonymous CF patients or anti-PaAP antibodies,
and developed with SuperSignal (Pierce).
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